8 completed, 2 unknown, 1 recruiting, 1 terminated. 4 Phase 4, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Unknown 2, Completed 1, Terminated 1 |
| Phase 3 | 3 | Completed 3 |
Follow ARB: new trials by email Literature Review of ARB trials Research Report on ARB
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sacubitril/Valsartan for CKD5 Stage Dialysis Patients Sacubitril/Valsartan, Irbesartan - CKD5 Stage Dialysis, Heart Failure | Phase 4 | Completed | Ruijin Hospital | 330 | 2020-08-01 | 2023-03-17 |
| Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives Angiotensin-Converting Enzyme Inhibitors (ACE-I) and Angiotensin II Receptor Blockers (ARB) - COVID-19 | Completed | Hakeam Abdulaziz Hakeam | 314 | 2020-05-10 | 2020-08-04 | |
| Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection Antihistamine, Amantadine, ACEI - COVID19, Influenza Vaccination | Recruiting | Consorci Sanitari de Terrassa | 3000 | 2020-03-01 | 2026-03-25 | |
| ACEI or ARB and COVID-19 Severity and Mortality in US Veterans ACEI/ARB, Non-ACEI/ARB, ACEI - Hypertension, COVID | Completed | University of Utah | 22213 | 2020-01-19 | 2021-04-28 | |
| Randomized Evaluation of Beta Blocker and ACEI/ARB Treatment in MINOCA Patients - MINOCA-BAT Beta blocker, ACEI, ARB - Myocardial Infarction With Non-obstructive Coronary Arteries | Phase 4 | Terminated | Uppsala University | 198 | 2018-12-16 | 2023-11-27 |
| Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy Mycophenolate Mofetil, ACE inhibitor, Corticosteroid - IgA Nephropathy | Phase 4 | Unknown | Yonsei University | 100 | 2016-06-01 | 2016-12-05 |
| SUrvey of Guideline Adherence for Treatment of Systolic Heart Failure in Real World guideline adherence - Heart Failure, Congestive | Completed | GlaxoSmithKline | 1 | 2011-03-01 | 2012-11-30 | |
| The Use of Angiotensin Receptor Blockers and the Risk of Cancer ARB, ACEI, Beta-blockers - Neoplasm | Completed | Boehringer Ingelheim | 1165781 | 2011-02-01 | 2014-08-13 | |
| Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD) ARB, Pentoxifylline, Placebo (for Pentoxifylline) - Chronic Renal Failure | Phase 4 | Unknown | National Taiwan University Hospital | 350 | 2010-06-01 | 2016-10-14 |
| Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts tacrolimus, Simulect, Cellcept - Kidney Transplantation | Phase 3 | Completed | Astellas Pharma Inc | 281 | 2009-08-17 | 2024-11-01 |
| HALT Progression of Polycystic Kidney Disease Study B Lisinopril, Telmisartan, Placebo - Kidney, Polycystic | Phase 3 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 486 | 2006-01-01 | 2020-04-22 |
| HALT Progression of Polycystic Kidney Disease Study A Lisinopril, Telmisartan, Placebo - Kidney, Polycystic | Phase 3 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 558 | 2006-01-01 | 2020-04-21 |
Hypertension (3) · COVID-19 (2) · Disease (2) · Familial paroxysmal dystonia (2) · Heart Failure (2) · Polycystic Kidney Diseases (2) · Polycystic Kidney, Autosomal Dominant (2) · Glomerulonephritis, IGA (1) · Heart Failure, Systolic (1) · Influenza, Human (1) · Kidney Failure, Chronic (1) · MINOCA (1) · Myocardial Infarction (1) · Neoplasms (1) · Renal Insufficiency, Chronic (1)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (2) · Astellas Pharma Inc (1) · Boehringer Ingelheim (1) · Consorci Sanitari de Terrassa (1) · GlaxoSmithKline (1) · Hakeam Abdulaziz Hakeam (1) · National Taiwan University Hospital (1) · Ruijin Hospital (1) · University of Utah (1) · Uppsala University (1) · Yonsei University (1)
United States (3) · South Korea (2) · Spain (2) · Australia (1) · Canada (1) · China (1) · New Zealand (1) · Norway (1) · Saudi Arabia (1) · Sweden (1) · Taiwan (1)
Arlene Chapman, M.D. (2) · Marva Moxey-Mims, M.D. (2) · Robert Schrier, M.D. (2) · Ronald Perrone, M.D. (2) · Vicente Torres, M.D. (2) · Adam P Bress, PharmD, MS (1) · Bertil Lindahl, Prof (1) · Charity G Moore, MS,PhD (1) · Charity G Moore, PhD (1) · Hakeam A Hakeam, MSPharm BCPS (1)
PMID 39356039, PMID 22205355, PMID 25111236, PMID 25399731, PMID 25399733, PMID 30582281, PMID 30803434, PMID 33203618, PMID 33231487, PMID 33891615, PMID 36918388, PMID 37250503, PMID 39082471, PMID 39459868, PMID 39739990, PMID 40508884, PMID 41198855, PMID 42246870
U01DK062401 (2), U01DK082230 (2)